ANTHEM BIOSCIENCES
|
The Current P/S Ratio of ANTHEM BIOSCIENCES is 24.61.
| Share Price | ₹874.4 | Sep 25,2026 |
| Market Cap | ₹49,269.6 Cr | |
| Sales-TTM | ₹2,002.3 Cr | TTM-Consolidated Results |
| Price/Sales | 24.61x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ANTHEM BIOSCIENCES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹49,269.6 Cr] as on Sep 25,2026
(/) Sales [ ₹2,002.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 24.61x ]
Thus, for ANTHEM BIOSCIENCES , the investors are currently willing to pay '24.61 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ANTHEM BIOSCIENCES !
The chart below summarizes the trend in P/S Ratio of ANTHEM BIOSCIENCES over the last five years.
Historical PS (Price/Sales) ratio chart of ANTHEM BIOSCIENCES
PS Ratio Performance Analysis for ANTHEM BIOSCIENCES
- ANTHEM BIOSCIENCES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 3.47x.
- ANTHEM BIOSCIENCES 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ANTHEM BIOSCIENCES 's p/e ratio peaked in Mar2026 at 17.35x.
- ANTHEM BIOSCIENCES 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does ANTHEM BIOSCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ANTHEM BIOSCIENCES | 2,002.3 | 24.61 | 49,269.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.42 | 444,717.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.72 | 255,115.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.06 | 189,613.0 |
| CIPLA LTD | 28,324.4 | 3.99 | 112,876.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 3.02 | 100,395.0 |
| MANKIND PHARMA LTD | 14,737.9 | 6.94 | 102,247.0 |
| LUPIN LTD | 29,966.6 | 3.19 | 95,573.6 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.19 | 119,900.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.82 | 98,464.4 |
| LAURUS LABS LTD | 7,269.6 | 14.87 | 108,116.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ANTHEM BIOSCIENCES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.82x |
| Max industry PS | 24.61x |
| Median industry PS | 6.94x |
| Average industry PS | 9.62x |
You may also like the below Video Courses